Emisphere Technologies Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
Emisphere Technologies General Information
Description
Emisphere Technologies Inc is a pharmaceutical and drug delivery company. It aims to partner its proprietary drug delivery technology and license its first medical food product Eligen B12, which is used to normalize vitamin B12 levels without an injection. The company is in partnership with global pharmaceutical companies to develop new oral formulations of existing injectable bio-pharmaceutical products, as well as new chemical entities, using its Eligen Technology. The company recognizes its revenues from the sales of Eligen B12, and prescription product sales.
Contact Information
Website
www.emisphere.comCorporate Office
- 4 Becker Farm Road
- Suite 103
- Roseland, NJ 07068
- United States
Corporate Office
- 4 Becker Farm Road
- Suite 103
- Roseland, NJ 07068
- United States
Emisphere Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Emisphere Technologies Comparisons
Industry
Financing
Details
Emisphere Technologies Competitors (9)
One of Emisphere Technologies’s 9 competitors is Oramed Pharmaceuticals, a Corporation company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals | Corporation | New York, NY | ||||
| Rani Therapeutics | Formerly VC-backed | San Jose, CA | ||||
| Avenir Wellness Solutions | Formerly VC-backed | Oxnard, CA | ||||
| SynCore Biotechnology Company | Corporation | Yilan City, Taiwan | ||||
| Aytu Biopharma | Corporation | Denver, CO |
Emisphere Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Emisphere Technologies Patents
Emisphere Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2013305664-A1 | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | Active | 23-Aug-2012 | ||
| AU-2013305664-B2 | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | Active | 23-Aug-2012 | ||
| CA-2882719-A1 | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | Active | 23-Aug-2012 | ||
| CA-2882719-C | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | Active | 23-Aug-2012 | ||
| EP-2888224-A1 | Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents | Active | 23-Aug-2012 | C07C217/62 |
Emisphere Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Emisphere Technologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Emisphere Technologies FAQs
-
When was Emisphere Technologies founded?
Emisphere Technologies was founded in 1985.
-
Where is Emisphere Technologies headquartered?
Emisphere Technologies is headquartered in Roseland, NJ.
-
What is the size of Emisphere Technologies?
Emisphere Technologies has 6 total employees.
-
What industry is Emisphere Technologies in?
Emisphere Technologies’s primary industry is Drug Delivery.
-
Is Emisphere Technologies a private or public company?
Emisphere Technologies is a Private company.
-
What is the current valuation of Emisphere Technologies?
The current valuation of Emisphere Technologies is .
-
What is Emisphere Technologies’s current revenue?
The current revenue for Emisphere Technologies is .
-
How much funding has Emisphere Technologies raised over time?
Emisphere Technologies has raised $30.8M.
-
Who are Emisphere Technologies’s investors?
Foresite Capital and MHR Fund Management have invested in Emisphere Technologies.
-
Who are Emisphere Technologies’s competitors?
Oramed Pharmaceuticals, Rani Therapeutics, Avenir Wellness Solutions, SynCore Biotechnology Company, and Aytu Biopharma are some of the 9 competitors of Emisphere Technologies.
-
When was Emisphere Technologies acquired?
Emisphere Technologies was acquired on 08-Dec-2020.
-
Who acquired Emisphere Technologies?
Emisphere Technologies was acquired by Novo Nordisk.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
